These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36158702)

  • 21. Combination pharmacotherapy for neuropathic pain: current evidence and future directions.
    Gilron I; Max MB
    Expert Rev Neurother; 2005 Nov; 5(6):823-30. PubMed ID: 16274339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges of neuropathic pain: focus on diabetic neuropathy.
    Rosenberger DC; Blechschmidt V; Timmerman H; Wolff A; Treede RD
    J Neural Transm (Vienna); 2020 Apr; 127(4):589-624. PubMed ID: 32036431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational neuropathic pain research: A clinical perspective.
    Bouhassira D; Attal N
    Neuroscience; 2016 Dec; 338():27-35. PubMed ID: 26995083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned.
    Keppel Hesselink JM
    Drug Dev Res; 2017 Mar; 78(2):75-80. PubMed ID: 28195646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
    Cavalli E; Mammana S; Nicoletti F; Bramanti P; Mazzon E
    Int J Immunopathol Pharmacol; 2019; 33():2058738419838383. PubMed ID: 30900486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathic pain.
    Smith TE; Chong MS
    Hosp Med; 2000 Nov; 61(11):760-6. PubMed ID: 11198743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging biomarkers and the role of neuroinflammation in neuropathic pain.
    Chang L; Cooper MS; Clark VP
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):448-51. PubMed ID: 23666404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies.
    Smith MT; Anand P; Rice ASC
    Pain; 2016 Feb; 157 Suppl 1():S33-S41. PubMed ID: 26785154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons.
    Yeh TY; Luo IW; Hsieh YL; Tseng TJ; Chiang H; Hsieh ST
    Cells; 2020 Dec; 9(12):. PubMed ID: 33371371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem Cells in the Treatment of Neuropathic Pain: Research Progress of Mechanism.
    Liu M; Li K; Wang Y; Zhao G; Jiang J
    Stem Cells Int; 2020; 2020():8861251. PubMed ID: 33456473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoids in the Treatment of Neuropathic Pain.
    Rao PN; Mainkar O; Bansal N; Rakesh N; Haffey P; Urits I; Orhurhu V; Kaye AD; Urman RD; Gulati A; Jones M
    Curr Pain Headache Rep; 2021 May; 25(7):43. PubMed ID: 33961144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Top 100 Most-Cited Papers in Neuropathic Pain From 2000 to 2020: A Bibliometric Study.
    Xiong HY; Liu H; Wang XQ
    Front Neurol; 2021; 12():765193. PubMed ID: 34867750
    [No Abstract]   [Full Text] [Related]  

  • 33. The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives.
    Bimonte S; Cascella M; Schiavone V; Mehrabi-Kermani F; Cuomo A
    Drug Des Devel Ther; 2017; 11():2737-2742. PubMed ID: 29066865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concise review: stem cell therapies for neuropathic pain.
    Fortino VR; Pelaez D; Cheung HS
    Stem Cells Transl Med; 2013 May; 2(5):394-9. PubMed ID: 23572051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.
    Percie du Sert N; Rice AS
    Br J Pharmacol; 2014 Jun; 171(12):2951-63. PubMed ID: 24527763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain.
    Casey SL; Vaughan CW
    Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29966400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic treatment of neuropathic pain.
    Wallace MS
    Curr Pain Headache Rep; 2001 Apr; 5(2):138-50. PubMed ID: 11252148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.
    Lafreniere JD; Kelly MEM
    Neuronal Signal; 2018 Dec; 2(4):NS20170144. PubMed ID: 32714590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
    Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
    J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain.
    Megat S; Ray PR; Moy JK; Lou TF; Barragán-Iglesias P; Li Y; Pradhan G; Wanghzou A; Ahmad A; Burton MD; North RY; Dougherty PM; Khoutorsky A; Sonenberg N; Webster KR; Dussor G; Campbell ZT; Price TJ
    J Neurosci; 2019 Jan; 39(3):393-411. PubMed ID: 30459229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.